Skip to main content

Ezetimibe use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Aug 30, 2023.

Drugs containing Ezetimibe: Zetia, Vytorin, Nexlizet, Liptruzet, Roszet, Lypqozet

Ezetimibe Levels and Effects while Breastfeeding

Summary of Use during Lactation

No relevant published information exists on the use of ezetimibe during breastfeeding. Because of a concern with disruption of infant lipid metabolism, ezetimibe is best avoided during breastfeeding. An alternate drug is preferred, especially while nursing a newborn or preterm infant. Ezetimibe treatment in combination with a statin (e.g., atorvastatin, simvastatin) should be avoided in nursing mothers.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Cholestyramine, Colesevelam, Colestipol

Substance Identification

Substance Name

Ezetimibe

CAS Registry Number

163222-33-1

Drug Class

Breast Feeding

Lactation

Anticholesteremic Agents

Antilipemic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.